Retreatment with interferon for chronic hepatitis C after transient response

Area of Science:

• Hepatology
• Virology
• Gastroenterology

Background:

• Chronic hepatitis C (HCV) infection often shows initial response to interferon but low sustained response rates.
• Identifying predictors for sustained response after interferon retreatment is crucial for patient management.

Purpose of the Study:

• To evaluate the efficacy of interferon retreatment in chronic hepatitis C patients who relapsed after initial treatment.
• To identify factors predicting sustained biochemical and virologic response to retreatment.

Main Methods:

• Thirty patients with relapsed chronic hepatitis C were retreated with interferon.
• Patient data, including pre-retreatment viral load, histologic grade, and treatment intervals, were analyzed.
• Outcomes assessed included end-of-retreatment biochemical response and sustained aminotransferase normalization with HCV RNA clearance.

Main Results:

• All patients showed biochemical response at the end of retreatment.
• 33% of patients achieved sustained response (normalization of aminotransferases and HCV RNA clearance).
• Low pre-retreatment viral load, shorter intervals between treatments, and lower histologic grades were associated with sustained response in univariate analysis.
• Multivariate analysis identified pre-retreatment viral load as the sole significant predictor of sustained response.

Conclusions:

• Interferon retreatment is a viable option for chronic hepatitis C patients with transient responses.
• Pre-retreatment hepatitis C virus (HCV) viral load is a key determinant for achieving sustained response after interferon retreatment.